Carisma Therapeutics
ID: 5330263Carisma Therapeutics is a biotechnology company founded in 2016 to bring the potheyr of adoptive cellular immunotherapy to solid tumor patients through a novel platform using chimeric antigen receptor macrophages (CARMA).
2
Funding Rounds
$112.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Re**** Ho**** | - | - | |
| Ma******* Ch**** | - | - | |
| St**** Ke*** |
|
- | |
| Br**** Mo****** | - | - | |
| Bj**** Od****** | - | - | |
| Ch****** Ug***** | - | - |
Funding series
Funding Series Analysis
The company Carisma Therapeutics has raised a total of $59m in funding over 2 rounds.
Key Insights:
- Carisma Therapeutics Series B round, March 2021: $59m
- Carisma Therapeutics Series A round, June 2018: $53m
Industries
Carisma Therapeutics is active in the following industries: